HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preclinical evaluation of a humanized NR-LU-10 antibody-streptavidin fusion protein for pretargeted cancer therapy.

Abstract
A humanized single chain Fv antibody fragment specific to the EGP40 antigen was genetically engineered as a streptavidin fusion (scFvSA) for use in pretargeted radioimmunotherapy. The scFvSA construct was expressed as a soluble, tetrameric species in the Escherichia coli periplasm at 110-140 mg/liter. The fusion protein was purified from crude lysates by iminobiotin affinity chromatography with an overall yield of 50-60%. Characterization of the purified protein by SDS-PAGE, light scattering, and size exclusion chromatography demonstrated that the fusion protein was tetrameric with a molecular weight of approximately 172,000. Competitive immunoreactivity assays showed a two-fold greater binding to the antigen than the comparable whole antibody. The purified protein had a biotin disassociation rate identical to recombinant streptavidin and bound an average of three of four possible biotins per molecule. The radiolabeled fusion protein showed a faster blood clearance rate in normal mice than the corresponding whole antibody-streptavidin chemical conjugate. Tumor-specific targeting of a subsequently administered radionuclidechelate/biotin molecule was demonstrated in nude mice bearing SW1222 human colon carcinoma xenografts. A single dose of 800 microCi of 90Y-DOTA-biotin produced cures in mice with established subcutaneous human small cell lung or colon cancer xenografts.
AuthorsS Goshorn, J Sanderson, D Axworthy, Y Lin, M Hylarides, J Schultz
JournalCancer biotherapy & radiopharmaceuticals (Cancer Biother Radiopharm) Vol. 16 Issue 2 Pg. 109-23 (Apr 2001) ISSN: 1084-9785 [Print] United States
PMID11385958 (Publication Type: Journal Article)
Chemical References
  • Antigens, Neoplasm
  • CD3 Complex
  • Cell Adhesion Molecules
  • Epithelial Cell Adhesion Molecule
  • Immunoglobulin Fragments
  • Iodine Radioisotopes
  • Recombinant Fusion Proteins
  • immunoglobulin Fv
  • Streptavidin
Topics
  • Animals
  • Antigens, Neoplasm (genetics, immunology)
  • CD3 Complex (genetics, immunology)
  • Cell Adhesion Molecules (genetics, immunology)
  • Colonic Neoplasms (drug therapy, metabolism)
  • Drug Evaluation, Preclinical
  • Electrophoresis, Polyacrylamide Gel
  • Epithelial Cell Adhesion Molecule
  • Escherichia coli (genetics, metabolism)
  • Female
  • Genetic Vectors
  • Humans
  • Immunoglobulin Fragments (therapeutic use)
  • Iodine Radioisotopes (administration & dosage)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Radioimmunotherapy
  • Recombinant Fusion Proteins (pharmacokinetics, therapeutic use)
  • Streptavidin (genetics, immunology)
  • Tissue Distribution
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: